Patents by Inventor Nicolas GUILLOTEAU

Nicolas GUILLOTEAU has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Specific inhibitors of cytochrome P450 26 retinoic acid hydroxylase
    Patent number: 9963439
    Abstract: The present disclosure is generally directed to compositions and methods for treating diseases that are ameliorated by the inhibition of CYP26 mediated retinoic acid metabolism. The compositions comprise compounds of formula (I).
    Type: Grant
    Filed: August 20, 2014
    Date of Patent: May 8, 2018
    Assignees: University of Washington Through Its Center For Commercialization, University of Montana
    Inventors: Philippe Diaz, Nina Isoherranen, Brian Buttrick, Nicolas Guilloteau
  • NOVEL AND SPECIFIC INHIBITORS OF CYTOCHROME P450 26 RETINOIC ACID HYDROXYLASE
    Publication number: 20160200703
    Abstract: The present disclosure is generally directed to compositions and methods for treating diseases that are ameliorated by the inhibition of CYP26 mediated retinoic acid metabolism. The compositions comprise compounds of formula (I).
    Type: Application
    Filed: August 20, 2014
    Publication date: July 14, 2016
    Applicant: UNIVERSITY OF MONTANA
    Inventors: Philippe DIAZ, Nina ISOHERRANEN, Brian BUTTRICK, Nicolas GUILLOTEAU